Rifampicin plus ceftriaxone versus vancomycin plus ceftriaxone in the treatment of penicillin- and cephalosporin-resistant pneumococcal meningitis in an experimental rabbit model


SUNTUR B., Yurtseven T. , Sipahi O. R. , BUKE C., BUKE M.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, cilt.26, ss.258-260, 2005 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 26 Konu: 3
  • Basım Tarihi: 2005
  • Doi Numarası: 10.1016/j.ijantimicag.2005.06.010
  • Dergi Adı: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
  • Sayfa Sayısı: ss.258-260

Özet

This study was planned to compare the efficacy of ceftriaxone + vancomycin with ceftriaxone + rifampicin in a rabbit model of penicillin and cephalosporin-resistant Streptococcus pneumoniae meningitis. Meningitis was induced by intracisternal inoculation of S. pneumoniae. After 18 h of incubation, Group I was given saline solution (control group), whilst Groups 2 and 3 were given ceftriaxone + vancomycin and ceftriaxone + rifampicin, respectively. Cerebrospinal fluid bacterial concentrations were, measured at 0, 2, 12, 14 and 24 h after therapy was initiated.. In the control group, bacterial growth was present at all time points, whereas no growth was observed in either the ceftriaxone + vancomycin group or the ceftriaxone + rifampicin group after 2 h of therapy. Ceftriaxone + rifampicin was found to be as effective as ceftriaxone + vancomycin in the treatment of penicillin-resistant S. pneumoniae meningitis in experimental rabbit model. (c) 2005 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.